
Please try another search
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
Name | Age | Since | Title |
---|---|---|---|
Agustin V. Gago | 63 | 2022 | Director |
Brent Willis | 54 | 2015 | President, CEO & Director |
Bradley Craig Willis | 54 | 2014 | Founder, COO & Director |
Eric S. Pommer | 74 | 2022 | Independent Chairperson |
C. Dan Johnson | - | - | Member of Scientific Advisory Board |
Sat Somers | - | - | Member of Scientific Advisory Board |
Kevin Richard McBeth | - | 2023 | Independent Director |
Deborah A. Baumgarten | - | - | Member of Scientific Advisory Board |
Alec J. Megibow | - | - | Member of Scientific Advisory Board |
Thomas Lauenstein | - | - | Member of Scientific Advisory Board |
Beth Shaw | - | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review